MEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery)

NCT00157716 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

900

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Bypass Graft Surgery
Myocardial Ischemia
Reperfusion Injury
Myocardial Revascularization

Interventions

DRUG: (MC-1) Pyridoxal-5'-phosphate

Sponsor

Medicure